New “Anti-Addiction” Patch to Combat Opioid Crisis and Treat PTSD

For Immediate Release

October 31, 2019                                                                                      

Gold River Productions, Inc. (GRPS) and RushNet, Inc. (RSHN) and Premier Biomedical Inc. and a Major Defense Contractor Collaborate on Development of New “Anti-Addiction” Patch to Combat Opioid Crisis and Treat PTSD

Palm Coast, FL, October 23, 2019 — Gold River Productions Inc. (OTC Pink: GRPS) (formerly XYZ Hemp, Inc.) and RushNet, Inc. (OTC Pink: RSHN) partnered with Premier Biomedical Inc. (OTCQB: BIEI) to develop one of the most promising tools yet in the worldwide fight against drug abuse and the opioid crisis. Together, the companies have developed a transdermal patch containing a strategic blend of BIEI’s patented combination of low-dose naloxone and cyclobenzaprine along with key elements of CBD. Preliminary indications in short-term and long-term addiction are exciting and the companies look forward to upcoming clinical trials.

Looking for an expeditious way to effectively deal with the opioid crisis, the companies are forging ahead on a strategic partnership with a large (soon to be named) defense contractor.

Richard Goulding, M.D., Chairman of the Board of GRPS and RSHN stated, “With the favorable political climate, it seems quite likely that we will commence clinical trials soon.  These chemicals in our unique formulation are not new, but the combination is unique and safe and patented.  We have been in close negotiations with a large defense contractor to fast-track our initiative and serve a growing section of our society that is in grave danger.  By titrating the number of patches, we are able to tailor a formula to a patient’s specific needs.  As a further aside, we’ve seen promise in other forms of addiction utilizing this same chemical formulation, including video game, sugar and even food addictions, opening up further markets and broadening potential benefit.”

“We started each company with one thing in mind,” says Dr. Goulding.  “We really want to make an impact on people’s suffering.  With 200,000 new addictions per year in the U.S. alone, 40,000 deaths in 2016, and a reported 275 million people around the world using illicit drugs, the positive impact of the Anti-Addiction Patch would be global in scope. And we are particularly sensitive to the disproportionate impact upon military personnel.”

Premier Biomedical’s Mitch Felder, M.D., neurologist and developer of Feldetrex further states, “In addition to anti addiction there have been initial promising results when the patch is applied to relieve symptoms in those suffering from PostTraumatic Stress Disorder (PTSD) and severe anxiety.  We’ve created a reliable, cost-effective and incredibly safe formula to titrate effective therapy for patients with a myriad of disorders for which availability of treatment was largely nonexistent.  We are very excited about our partnerships and see the next few months as critical.”

Anticipation for the patch within the medical community is extremely high and once approved, it is expected to be quickly integrated into treatment programs worldwide. For more information on the Anti-Addiction patch and its availability as well as development partners, we will be keeping the public advised on our website,

About Premier Biomedical Inc.:  Premier Biomedical is a unique company on the cutting edge of exciting new technologies that challenge traditional medicine and supply effective therapies for disease states that have little prior effective treatments.

About RushNet, Inc.: RushNet, Inc. is an eclectic company with ties to CBD.  From cultivation to unique products, Rushnet seeks a unique market share in a rapidly developing market.

About Gold River Production Services, Inc.: Gold River Productions is dedicated to changing peoples’ lives.  With a unique staff of physicians, cultivators, and CBD experts, we are poised to tackle different disease states on an unprecedented level.  Utilizing years of experience in herbals, rare cannabinoids, traditional and non-traditional methods of patient care, we are in the unique position to utilize CBD in the most effective ways possible.  Emphasis on what already works, then augmenting proven products with high-quality cannabinoids in therapeutic levels achieve unprecedented symptom control in a myriad of disease states.

About the joint venture between Gold River Productions Inc. and RushNet, Inc.: This joint venture is a unique effort to secure all areas of cannabis production (including hemp) from cultivation and manufacturing to distribution and retail, with an emphasis on unique products and high-quality CBD.  RushNet is more focused on product development, particularly edibles and beverages while Gold River Productions addresses the more scientific elements of these pursuits, using formulations found only in the formation of high-quality nutraceuticals. Together, they are able to facilitate the vertical integration envisioned. Both are acquiring and joint venturing with companies in all aspects of the cannabis field as they jointly pursue a fully integrated cannabis and hemp business model.

Safe Harbor Statement: This release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Such statements include any that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words “estimate”, “project”, “intend”, “forecast”, “anticipate”, “plan”, “planning”, “expect”, “believe”, “likely”, “should”, “could”, “would”, “may” or similar words or expressions. Such statements are not a guarantee of future performance and are subject to risks and uncertainties that could cause the company’s actual results and financial position to differ materially from those in such statements, which involve risks and uncertainties, including those relating to the Company’s ability to grow. Actual results may differ materially from those predicted and any reported should not be considered an indication of future performance. Potential risks and uncertainties include the Company’s operating history and resources, economic, competitive, and equity market conditions.


CONTACT: RushNet, Inc.